Oculis Holding has concluded subject enrolment for the Phase III DIAMOND-1 and DIAMOND-2 clinical trials of OCS-01 eye drops for diabetic macular oedema. These randomised, double-masked ...

Oculis Holding has concluded subject enrolment for the Phase III DIAMOND-1 and DIAMOND-2 clinical trials of OCS-01 eye drops for diabetic macular oedema. These randomised, double-masked, multi-centre ...

People with type 2 diabetes have a higher risk of developing high blood pressure. The exact link is unknown, but it’s thought to result from the two conditions having similar causes and risk ...

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an ...

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials ...

Macular edema is swelling in the eye's retina that causes blurry vision but can progress to more serious vision loss. The most common condition associated with macular edema is diabetic retinopathy, ...